Preijers, Tim
Bukkems, Laura
van Spengler, Max
Leebeek, Frank
Cnossen, Marjon
Mathôt, Ron http://orcid.org/0000-0001-8401-0879
Funding for this research was provided by:
CSL Behring
Article History
Received: 20 October 2020
Accepted: 11 February 2021
First Online: 24 February 2021
Declarations
:
: FL reports grants from CSL Behring, grants from Shire, grants from uniQure, other from uniQure, other from Shire, other from BioMarin, personal fees from Roche, and outside the submitted work. MC has received grants from governmental research institutes such as Dutch Research Institute (NWO), ZonMW, Innovation fund, NWO-NWA, and unrestricted investigator initiated research grants as well as educational and travel funding from the following companies over the years: Pfizer, Baxter/Baxalta/Shire, Bayer Schering Pharma, CSL Behring, Sobi Biogen, Novo Nordisk, Novartis and Nordic Pharma, and has served as a member on steering boards of Roche, Bayer, and Octapharma. All grants, awards, and fees go to the institution. RM reports grants from Bayer, grants from Shire, grants from Merck Sharpe Dome, grants from CSL Behring, other from Bayer, and other from Shire outside the submitted work. Other authors declare no competing financial interests.